Purnima Thakur, Sushmita Ghoshal, Mini Arora, Neeru Anand, Anu Sharma
E-mail: drpurnima_thakur@yahoo.co.in
Background: Cancer patients with limited life expectancy are often prescribed active cancer directed therapy. The WHO has emphasised the integrated approach to palliative care in the treatment of cancer patients. The present study is an audit at a centre in North India (PGIMER, Chandigarh) where palliative care is integrated with the oncology services with the aim to see the number of patients who received antineoplastic treatment in the last 30 days of their lives.
Methods: Case records of all patients registered in the palliative care clinic, who died during the period November 2013 to October 2014 were retrospectively analysed. The demographic data and treatment records were analysed to record the treatment delivered, during the last 30 days of their lives. Mean duration of survival from the time of diagnosis was calculated by Kaplan Meier method.
Results: During the study period of one year, 970 patients were registered in the palliative care clinic and 89 patients died. The overall survival was 20 months. Majority had stage III and IV disease at presentation, and 33 patients were given palliative care within 3 months of diagnosis. The mean duration of palliative care in this group was 3.3 months. The patients who received longer palliative care were satisfactorily relieved of cancer pain. In the last 30 days of their lives, 7 of 89 patients had received cancer-directed therapy: palliative RT in 5 patients and palliative chemotherapy in 2 patients.
Conclusion: Early integration of palliative care into cancer treatment can improve end-of-life care by providing symptom relief without futile and toxic antineoplastic therapy. One should choose judiciously between offering only palliative care or palliative care integrated with cancer-directed therapy in advanced stage cancers with limited life expectancy.
Key words: Audit, End-of-life care, Integrated approach
